BTI
DGX icon

Blue Trust Inc’s Quest Diagnostics DGX Stock Holding History

Blue Trust Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
1,090
+27
+3% +$5.3K ﹤0.01% 743
2026
Q1 		$208K Sell
1,063
-633
-37% -$123K ﹤0.01% 757
2025
Q4 		$294K Sell
1,696
-15
-0.9% -$2.73K ﹤0.01% 658
2025
Q3 		$326K Sell
1,711
-101
-6% -$17.9K ﹤0.01% 632
2025
Q2 		$325K Buy
1,812
+129
+8% +$22.4K ﹤0.01% 608
2025
Q1 		$285K Buy
1,683
+773
+85% +$127K ﹤0.01% 581
2024
Q4 		$137K Sell
910
-482
-35% -$75K ﹤0.01% 790
2024
Q3 		$191K Buy
1,392
+89
+7% +$13.3K ﹤0.01% 876
2024
Q2 		$173K Buy
1,303
+343
+36% +$47K ﹤0.01% 764
2024
Q1 		$128K Sell
960
-106
-10% -$13.8K ﹤0.01% 644
2023
Q4 		$130K Buy
1,066
+131
+14% +$17.2K ﹤0.01% 585
2023
Q3 		$132K Buy
935
+249
+36% +$33.2K ﹤0.01% 542
2023
Q2 		$97K Sell
686
-1,220
-64% -$168K ﹤0.01% 511
2023
Q1 		$298K Buy
1,906
+520
+38% +$74.4K ﹤0.01% 408
2022
Q4 		$170K Buy
1,386
+567
+69% +$81.5K ﹤0.01% 508
2022
Q3 		$109K Buy
819
+272
+50% +$35.8K ﹤0.01% 504
2022
Q2 		$75K Buy
+547
New +$74.5K ﹤0.01% 579

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Blue Trust Inc's DGX Position: Q2 2026 in Review

Blue Trust Inc increased its Quest Diagnostics (DGX) stake by 2.5% in Q2 2026, buying an estimated $5.3K and bringing the position to 1,090 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Blue Trust Inc first reported a position in DGX in Q2 2022 and has held it in 17 quarters since. The position peaked at $326K in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Blue Trust Inc held 1,090 shares of Quest Diagnostics worth $231K as of Q2 2026.
  • Blue Trust Inc bought 27 Quest Diagnostics shares in Q2 2026, an estimated $5.3K.
  • Quest Diagnostics made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #743 holding.
  • Blue Trust Inc first reported a position in Quest Diagnostics in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Quest Diagnostics position peaked at $326K in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.